Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Unknown × Injections, Subcutaneous × Clear all

Phase

Status

Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Cisplatin 245 Carboplatin 174 Oxaliplatin 164 Capecitabine 161 Docetaxel 157 apatinib 152 Paclitaxel 145 Gemcitabine 138 Bevacizumab 135 Radiotherapy 132 camrelizumab 129 Fluorouracil 128 Cyclophosphamide 116 Irinotecan 109 Drug Therapy 94 Etoposide 92 sintilimab 89 S 1 (combination) 77 Leucovorin 74 anlotinib 71 Doxorubicin 70 pembrolizumab 69 tislelizumab 67 Pemetrexed 67 toripalimab 66 Dexamethasone 62 Rituximab 61 Neoadjuvant Therapy 59 Cetuximab 58 Trastuzumab 57

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03899077 2024-02-07

SAVE

Cancer Research Antwerp

Phase 2 Unknown

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡